These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 21790809)

  • 1. Oestrogen receptors and signalling pathways: implications for neuroprotective effects of sex steroids in Parkinson's disease.
    Al Sweidi S; Sánchez MG; Bourque M; Morissette M; Dluzen D; Di Paolo T
    J Neuroendocrinol; 2012 Jan; 24(1):48-61. PubMed ID: 21790809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen receptors and gonadal steroids in vulnerability and protection of dopamine neurons in a mouse model of Parkinson's disease.
    Al-Sweidi S; Morissette M; Bourque M; Di Paolo T
    Neuropharmacology; 2011 Sep; 61(4):583-91. PubMed ID: 21586296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of oestrogen receptors on brain NMDA receptors of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice.
    Al-Sweidi S; Morissette M; Di Paolo T
    J Neuroendocrinol; 2012 Nov; 24(11):1375-85. PubMed ID: 22672467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen receptors and lesion-induced response of striatal dopamine receptors.
    Al Sweidi S; Morissette M; Rouillard C; Di Paolo T
    Neuroscience; 2013 Apr; 236():99-109. PubMed ID: 23357113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of estrogen receptors in neuroprotection by estradiol against MPTP toxicity.
    Morissette M; Jourdain S; Al Sweidi S; Menniti FS; Ramirez AD; Di Paolo T
    Neuropharmacology; 2007 Jun; 52(7):1509-20. PubMed ID: 17420033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signaling pathways mediating the neuroprotective effects of sex steroids and SERMs in Parkinson's disease.
    Bourque M; Dluzen DE; Di Paolo T
    Front Neuroendocrinol; 2012 Apr; 33(2):169-78. PubMed ID: 22387674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oestrogens prevent loss of dopamine transporter (DAT) and vesicular monoamine transporter (VMAT2) in substantia nigra of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice.
    Jourdain S; Morissette M; Morin N; Di Paolo T
    J Neuroendocrinol; 2005 Aug; 17(8):509-17. PubMed ID: 16011487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implication of the phosphatidylinositol-3 kinase/protein kinase B signaling pathway in the neuroprotective effect of estradiol in the striatum of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice.
    D'Astous M; Mendez P; Morissette M; Garcia-Segura LM; Di Paolo T
    Mol Pharmacol; 2006 Apr; 69(4):1492-8. PubMed ID: 16434614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Striatal Akt/GSK3 signaling pathway in the development of L-Dopa-induced dyskinesias in MPTP monkeys.
    Morissette M; Samadi P; Hadj Tahar A; Bélanger N; Di Paolo T
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Apr; 34(3):446-54. PubMed ID: 20026151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen receptors modulate striatal metabotropic receptor type 5 in intact and MPTP male mice model of Parkinson's disease.
    Al-Sweidi S; Morissette M; Di Paolo T
    J Steroid Biochem Mol Biol; 2016 Jul; 161():84-91. PubMed ID: 26873133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotection in Parkinsonian-treated mice via estrogen receptor α activation requires G protein-coupled estrogen receptor 1.
    Bourque M; Morissette M; Di Paolo T
    Neuropharmacology; 2015 Aug; 95():343-52. PubMed ID: 25892506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of estradiol on striatal dopamine activity of female hemiparkinsonian monkeys.
    Morissette M; Di Paolo T
    J Neurosci Res; 2009 May; 87(7):1634-44. PubMed ID: 19115413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dehydroepiandrosterone (DHEA) such as 17beta-estradiol prevents MPTP-induced dopamine depletion in mice.
    D'Astous M; Morissette M; Tanguay B; Callier S; Di Paolo T
    Synapse; 2003 Jan; 47(1):10-4. PubMed ID: 12422368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotective actions of sex steroids in Parkinson's disease.
    Bourque M; Dluzen DE; Di Paolo T
    Front Neuroendocrinol; 2009 Jul; 30(2):142-57. PubMed ID: 19410597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen and SERM neuroprotection in animal models of Parkinson's disease.
    Morissette M; Al Sweidi S; Callier S; Di Paolo T
    Mol Cell Endocrinol; 2008 Aug; 290(1-2):60-9. PubMed ID: 18515001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of striatal preproenkephalin mRNA levels in MPTP-lesioned mice treated with estradiol.
    D'Astous M; Morissette M; Callier S; Di Paolo T
    J Neurosci Res; 2005 Apr; 80(1):138-44. PubMed ID: 15723346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Broad neuroprotective profile of nicotinamide in different mouse models of MPTP-induced parkinsonism.
    Anderson DW; Bradbury KA; Schneider JS
    Eur J Neurosci; 2008 Aug; 28(3):610-7. PubMed ID: 18702732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotective properties of 17beta-estradiol, progesterone, and raloxifene in MPTP C57Bl/6 mice.
    Callier S; Morissette M; Grandbois M; Pélaprat D; Di Paolo T
    Synapse; 2001 Aug; 41(2):131-8. PubMed ID: 11400179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bak Foong protects dopaminergic neurons against MPTP-induced neurotoxicity by its anti-apoptotic activity.
    Liu B; Xie JX; Tsang LL; Rowlands DK; Ho LS; Gou YL; Chung YW; Chan HC
    Cell Biol Int; 2008 Jan; 32(1):86-92. PubMed ID: 17920944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of caffeine on the expression of cytochrome P450 1A2, adenosine A2A receptor and dopamine transporter in control and 1-methyl 4-phenyl 1, 2, 3, 6-tetrahydropyridine treated mouse striatum.
    Singh S; Singh K; Gupta SP; Patel DK; Singh VK; Singh RK; Singh MP
    Brain Res; 2009 Aug; 1283():115-26. PubMed ID: 19520064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.